Type 1 Diabetes program by RSSDI and Sanofi’s Social impact initiative has been delivering positive outcomes. The three-year ongoing collaboration between the Research Society for the Study of Diabetes in India (RSSDI) and Sanofi has begun to demonstrate a significant impact on the lives of